Max Planck Institute for Dynamics of Complex Technical Systems
Viral Glycocalix in Dependence on Host Cell Line, Influenza Virus Strain and Production Process Parameters
Glycoproteins, such as viral membrane protein hemagglutinin (HA) - the main antigen of influenza vaccines - can be considered as a collection of different glycoforms varying in structure of attached sugar residues (microheterogeneity) as well as in glycosylation site occupancy (macroheterogeneity). Since it is known that the glycosylation may significantly impact protein characteristics such as protein stability, antigenicity, immunogenicity, activity regulatory agencies usually demand glycosylation profiles for biopharmaceutical quality assurance. Since so far, there is only little known about the impact of glycosylation on vaccine efficiency and safety such regulations not yet exist for vaccines. However, first studies indicate a significant impact of glycosylation on vaccine immunogenicity, too.
Aim of the project
Using the developed high performance glycoanalysis system, the glycosylation patterns of viral surface proteins from unit operations in up- and downstream processing can be characterized. The main questions addressed regarding the glycosylation of HA, which is the most abundant and immunogenic influenza glycoprotein, are e.g.: the influence of host cell lines and virus strains [1,2], the impact of adaptation processes [3,4], changes due to modifications in cultivation conditions [5,6,7] and its impact on immunogenicity .
Schwarzer, J.; Rapp, E.; Reichl, U.: N-Glycan Analysis by CGE-LIF – Profiling Influenza A Virus Hemagglutinin N-Glycosylation during Vaccine Production. Electrophoresis 29 (20), pp. 4203 - 4214 (2008)
Genzel, Y.; Dietzsch, C.; Rapp, E.; Schwarzer, J.; Reichl, U.: MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Applied Microbiology and Biotechnology 88 (2), pp. 461 - 475 (2010)
Roedig, J.; Rapp, E.; Höper, D.; Genzel, Y.; Reichl, U.: Impact of Host Cell Line Adaptation on Quasispecies Composition and Glycosylation of Influenza A Virus Hemagglutinin. PLoS One 6 (12), p. e27989 (2011)
Rödig, J. V.; Rapp, E.; Bohne, J.; Kampe, M.; Kaffka, H.; Bock, A.; Genzel, Y.; Reichl, U.: Impact of Cultivation Conditions on N-glycosylation of Influenza Virus A Hemagglutinin Produced in MDCK Cell Culture. Biotechnology and Bioengineering 110 (6), pp. 1691 - 1703 (2013)
Hennig, R.; Rapp, E.; Kottler, R.; Cajic, S.; Reichl, U.: N -Glycosylation Fingerprinting of Viral Glycoproteins by xCGE-LIF. In: Carbohydrate-Based Vaccines: Methods and Protocols, pp. 123 - 143. Springer, New York (2015)